We are live on ! Find out more
CFB

Cullen/Frost Bankers Portfolio holdings

AUM $10.1B
1-Year Est. Return 29.18%
This Fund
S&P 500
This Quarter Est. Return
+8.71%
1 Year Est. Return
+29.18%
3 Year Est. Return
+91.06%
5 Year Est. Return
+115.39%
10 Year Est. Return
+478.9%
AUM
$3.66B
AUM Growth
+$288M
Cap. Flow
+$21M
Cap. Flow %
0.57%
Top 10 Hldgs %
22.73%
Holding
1,119
New
113
Increased
294
Reduced
320
Closed
71

Top Buys

Rank Stock Value
1
NKE icon
Nike
NKE
+$9.8M
2
BMY icon
Bristol-Myers Squibb
BMY
+$7.08M
3
PM icon
Philip Morris
PM
+$4.77M
4
STZ icon
Constellation Brands
STZ
+$4.29M
5
PB icon
Prosperity Bancshares
PB
+$4.21M

Sector Composition

Rank Sector Weight
1 Technology 15.63%
2 Financials 15.05%
3 Healthcare 11.78%
4 Consumer Discretionary 10.36%
5 Communication Services 8.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AXP icon
51
American Express
AXP
$231B
$21.1M 0.58%
169,307
-8,389
-5% -$1M
NFLX icon
52
Netflix
NFLX
$312B
$20.8M 0.57%
643,930
-46,050
-7% -$1.37M
RTN
53
DELISTED
Raytheon Company
RTN
$20.6M 0.56%
93,758
-682
-0.7% -$144K
NDAQ icon
54
Nasdaq
NDAQ
$53.6B
$20.3M 0.56%
569,844
-15,549
-3% -$530K
RDS.B
55
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
$20.2M 0.55%
336,484
+1,176
+0.4% +$69.2K
AMT icon
56
American Tower
AMT
$79.4B
$19.8M 0.54%
85,933
-1,233
-1% -$269K
GLW icon
57
Corning
GLW
$137B
$19.1M 0.52%
656,676
-23,081
-3% -$670K
BKNG icon
58
Booking.com
BKNG
$160B
$19.1M 0.52%
232,700
-600
-0.3% -$47.1K
BSX icon
59
Boston Scientific
BSX
$74.1B
$19.1M 0.52%
422,009
+11,076
+3% +$463K
DVY icon
60
iShares Select Dividend ETF
DVY
$23.6B
$19.1M 0.52%
180,452
-5,140
-3% -$529K
VUG icon
61
Vanguard Morningstar Growth ETF
VUG
$229B
$18.7M 0.51%
614,574
+7,044
+1% +$203K
C icon
62
Citigroup
C
$229B
$18.5M 0.51%
231,820
-2,988
-1% -$221K
MCO icon
63
Moody's
MCO
$83.1B
$18.1M 0.49%
76,165
-1,874
-2% -$416K
TJX icon
64
TJX Companies
TJX
$173B
$17.6M 0.48%
288,630
-8,974
-3% -$531K
HUM icon
65
Humana
HUM
$45.1B
$17.2M 0.47%
46,878
-561
-1% -$178K
BRK.B icon
66
Berkshire Hathaway Class B
BRK.B
$1.11T
$17.1M 0.47%
75,300
+18,458
+32% +$4.01M
VLO icon
67
Valero Energy
VLO
$93.1B
$17M 0.46%
181,138
-10,496
-5% -$992K
EW icon
68
Edwards Lifesciences
EW
$53.6B
$16.7M 0.46%
215,049
-3,096
-1% -$242K
FNF icon
69
Fidelity National Financial
FNF
$13B
$16.7M 0.46%
382,751
-11,066
-3% -$491K
KSU
70
DELISTED
Kansas City Southern
KSU
$16.5M 0.45%
107,505
-7,277
-6% -$1.07M
COF icon
71
Capital One
COF
$135B
$16.2M 0.44%
157,818
-3,835
-2% -$370K
WDAY icon
72
Workday
WDAY
$45B
$16.2M 0.44%
98,593
+5,074
+5% +$842K
TSN icon
73
Tyson Foods
TSN
$19.8B
$15.8M 0.43%
173,349
-1,129
-0.6% -$97.1K
BABA icon
74
Alibaba
BABA
$308B
$15.7M 0.43%
73,975
-17,063
-19% -$3.2M
VRTX icon
75
Vertex Pharmaceuticals
VRTX
$134B
$15.1M 0.41%
69,030
+4,446
+7% +$900K

Similar funds

Cullen/Frost Bankers's Q4 2019 Portfolio in Review

As of Q4 2019, Cullen/Frost Bankers held 1,119 positions worth $3.66B, up 8.5% from $3.37B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Cullen/Frost Bankers's Q4 2019 filing shows 113 new, 294 increased, 320 reduced and 71 closed positions. Its largest new stake was Albemarle: 6,600 shares worth $482K. The largest sale was Ulta Beauty, an estimated $7.43M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.

  • Cullen/Frost Bankers's largest Q4 2019 buy was Albemarle: 6,600 shares worth $482K.
  • Cullen/Frost Bankers added most to Nike in Q4 2019, an estimated $9.8M increase.
  • Cullen/Frost Bankers's biggest Q4 2019 reduction was Ulta Beauty, cutting an estimated $7.43M.
  • Cullen/Frost Bankers fully exited LegacyTexas Financial Group Inc in Q4 2019, selling an estimated $4.88M.
  • Cullen/Frost Bankers's ten largest holdings make up 23% of its $3.66B portfolio in Q4 2019.
  • Cullen/Frost Bankers opened 113 new positions and closed 71 in Q4 2019.
  • Cullen/Frost Bankers's portfolio value rose 8.5% quarter-over-quarter to $3.66B.

Based on Cullen/Frost Bankers's 13F filing for Q4 2019, filed 6 Feb 2020.